vTv Therapeutics LLC (vTv) is a clinical-stage pharmaceutical company focused on treating metabolic and inflammatory disorders to minimize their long-term complications and improve the lives of patients. Our mission is to advance clinical drug candidates discovered with our innovative technology into safe and effective medicines.
vTv has an innovative pipeline of first-in-class small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of metabolic and inflammatory disorders such as type 1 diabetes and psoriasis. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality of vTv’s product candidate pipeline, scientific team, clinical trial execution and strategic collaborations have enabled it to become a leader in its novel therapeutic targets.